Regencell Bioscience Holdings Limited RGC
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | -38.49% | -38.49% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -96.20% | -96.20% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 30.87% |
| Total Current Assets | -64.21% | -64.21% | -39.58% | -39.58% | -33.01% |
|
|
|||||
| Total Current Assets | -64.21% | -64.21% | -39.58% | -39.58% | -33.01% |
| Net Property, Plant & Equipment | -- | -- | 235.45% | 235.45% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -89.54% | -89.54% | -4.81% | -4.81% | 38.96% |
| Total Assets | -59.71% | -59.71% | -31.79% | -31.79% | -28.60% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -- | -- | 178.05% | 178.05% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 423.08% | 423.08% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -70.24% | -70.24% | -- |
| Total Other Current Liabilities | -- | -- | -70.24% | -70.24% | -- |
| Total Current Liabilities | -- | -- | 242.82% | 242.82% | -- |
|
|
|||||
| Total Current Liabilities | -- | -- | 242.82% | 242.82% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 794.21% | 794.21% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 144.34% |
| Total Liabilities | 134.88% | 134.88% | 307.88% | 307.88% | 144.34% |
|
|
|||||
| Common Stock & APIC | 372.99% | 372.99% | 0.82% | 0.82% | -33.92% |
| Retained Earnings | -- | -- | -16.58% | -16.58% | -- |
| Treasury Stock & Other | -- | -- | -41.48% | -41.48% | -- |
| Total Common Equity | -81.84% | -81.84% | -40.86% | -40.86% | -33.92% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -81.84% | -81.84% | -40.86% | -40.86% | -33.92% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -81.84% | -81.84% | -40.86% | -40.86% | -33.92% |
|
|
|||||